In 2025, Kosuke Kato and team from Emory University studied psilocin, the active compound in magic mushrooms, in human cells and 19-month-old mice (equivalent to ~60-year-old humans). They treated cells with psilocin and gave mice monthly psilocybin doses for weeks, measuring cell lifespan, mouse survival, and aging signs like fur condition.